ArticleImmunoTargets and therapy2024

Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment.

Xiaoling Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.